Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

35.01
Delayed Data
As of Jul 31
 +0.03 / +0.09%
Today’s Change
18.23
Today|||52-Week Range
42.48
+76.82%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close34.98
Today’s open35.22
Day’s range34.70 - 35.94
Volume297,279
Average volume (3 months)381,504
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio171.5
Price/Sales10.36
Price/Book10.75

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.65+2.05%
MGNXMacroGenics Inc+0.44+1.18%
CLLSCellectis SA+1.27+3.68%
RPTPRaptor Pharmaceutica...+0.11+0.78%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts